Device Trial Radar · NCT07950774
Pulmonary Near-infrared Spectroscopy to Predict the Need for Surfactant in Very Low Birth Weight Infants
Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
100
Planned (sponsor's estimate)
Start
Dec 1, 2026
Primary completion
Dec 30, 2027
Study completion Dec 31, 2027
Sponsor
- Lead sponsor
- University of StellenboschAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Medtronic
- First posted
- Nov 20, 2026
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 26 weeks, up to 32 weeks
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will look at whether a monitoring method called near-infrared spectroscopy (NIRS), can help assess lung disease in premature babies. The main aim of this study is to describe lung oxygen levels measured by NIRS in premature babies with respiratory distress syndrome (RDS) during the first 72 hours after birth. The study will include babies born at or before 32 weeks of pregnancy who need continuous positive airway pressure (CPAP) for RDS. The study will also assess whether these lung oxygen measurements can help predict which babies will need surfactant treatment, and whether they can predict which babies may need more than one dose of surfactant. The study will also compare lung NIRS measurements with other ways of assessing breathing problems, including lung ultrasound scores and oxygen-related measurements. In addition, the researchers will compare lung oxygen measurements with brain oxygen measurements. They will also look at whether surfactant treatment changes oxygen levels in the lungs and brain. Information from routine vital signs, such as heart rate, breathing rate, and oxygen saturation, will also be studied to see whether these measurements can help predict the need for surfactant. Added to this researchers will look at the hemodynamics of surfactant administration by seeing how the heart and blood vessels react to surfactant administration
Conditions
- Neonatal Respiratory Distress
Interventions
Pulmonary near-infra-red spectroscopyDevice
Pulmonary near-infrared spectroscopy sensors will be placed in a horizontal position
Primary outcomes
What the sponsor says the trial is designed to measure.
- PRSO2 valuesTime frame: 72 hours
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Tygerberg Hospital
Cape Town, South Africa · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.